World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A progress report

American Journal of Clinical Pathology

Volumn 111, Issue 1 SUPPL. 1, 1999, Pages

  Jaffe, Elaine S ^a,e   Harris, Nancy L ^b   Diebold, Jacques ^c   Muller Hermelink, Hans Konrad ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HÔTEL DIEU   (France)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e MSC 1500 ^*  (United States)

Author keywords

B cell; Hodgkin's disease; Leukemia; Lymphoma; Non Hodgkin's lymphoma; T cell

Indexed keywords

B CELL LYMPHOMA; CANCER CLASSIFICATION; HISTIOCYTIC LYMPHOMA; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA; MYELOID LEUKEMIA; PRIORITY JOURNAL; REVIEW; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; LYMPHOMA; WORLD HEALTH ORGANIZATION;

EID: 0032925443     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Mathe G, Rappaport H, O'Conor GT, et al. Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. In: International Histological Classification of Tumours. Vol 14. Geneva, Switzerland: World Health Organization; 1976:45.
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
3. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
4. Jaffe ES, Harris NL, Chan JKC, et al. Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol. 1997;21:114-121.
5. Non-Hodgkin's lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a Working Formulation for clinical usage. Cancer. 1982;49: 2112-2135.
6. Classification of non-Hodgkin's lymphomas: reproducibility of major classification systems. Cancer. 1985;55:91-95.
7. Lukes R, Collins R. Immunologic characterization of human malignant lymphomas. Cancer. 1974;34:1488-1503.
8. Nathwani B, Dixon D, Jones S, et al. The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group. Blood. 1982;60:1068-1074.
9. Lennert K, Feller A. Histopathology of Non-Hodgkin's Lymphomas. 2nd ed. New York, NY: Springer-Verlag; 1992.
10. Noorduyn LA, Van der Valk P, Van Heerde P, et al. Stage is a better prognostic indicator than morphologic subtype in primary non-cutaneous T-cell lymphoma. Am J Clin Pathol. 1990;93:49-57.
11. Armitage JO, Vose JM, Linder J, et al. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol. 1989;7:1783-1790.
12. A predictive model for aggressive non-Hodgkin's lymphoma: the International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987-994.
13. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/NK cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.
14. Moller P, Moldenhauer G, Momburg F, et al. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood. 1987;69:1087-1095.
15. Lamarre L, Jacobson J, Aisenberg A, et al. Primary large cell lymphoma of the mediastinum. Am J Surg Pathol. 1989;13: 730-739.
16. Gaulard P, Zafrani ES, Mavier P, et al. Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases. Hepatology. 1986;6:864-868.
17. Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood. 1996;88: 4265-4274.
18. Gonzalez CL, Medeiros LJ, Braziel RM, et al. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17-27.
19. Kumar S, Krenacs L, Elenitoba-Johnson K, et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T-lymphocytes. Hum Pathol. 1998;29:397-403.
20. Foss HD, Anagnostopoulos I, Araujo I, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood. 1996;88:4005-4011.
21. Pittaluga S, Wiodarska I, Pulford K, et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol. 1997;151:343-351.
22. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucelophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394-1404.
23. Wellman A, Otsuki T, Vogelbruch M, et al. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's of T-cell phenotype, and in Hodgkin's disease. Blood. 1995;86:2321-2328.
24. DeCoteau JF, Butmarc JR, Kinney MC, et al. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996;87:3437-3441.
25. Raphael MM, Audouin J, Lamine M, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas: correlation with histologic features in 36 cases: French Study Group of Pathology for HIV-Associated Tumors. Am J Clin Pathol. 1994;101:773-782.
26. Yano T, van Krieken KJ, Magrath IT, et al. Histogenic correlations between subcategories of small noncleaved cell lymphomas. Blood. 1992;79:1282-1290.